References
- Jaffe R, Weiss LM, Facchetti F. Tumours derived from Langerhans cells. In: Swerdlow SH, Campo E, Harris NL, et al editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp 358–360.
- Pileri SA, Orazi A, Falini B. Myeloid sarcoma. In: Swerdlow SH, Campo E, Harris NL, et al editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp 140–141.
- Pileri SA, Ascani S, Cox MC, et al Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007;21:340–350.
- Edelweiss M, Medeiros LJ, Suster S, Moran CA. Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases. Hum Pathol 2007;38:1463–1469.
- Chikwava K, Jaffe R. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Pediatr Dev Pathol 2004;7:607–614.
- Weir EG, Ali Ansari-Lari M, Batista DA, et al Acute bilineal leukemia: a rare disease with poor outcome. Leukemia 2007;21:2264–2270.
- Gianotti F, Caputo R. Histiocytic syndromes: a review. J Am Acad Dermatol 1985;13:383–404.
- Solano T, España A, Sola J, López G. Langerhans' cell histiocytosis on the vulva. Gynecol Oncol 2000;78:251–254.
- Egeler RM, Neglia JP, Aricò M, et al The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am 1998;12:369–378.
- Egeler RM, Neglia JP, Puccetti DM, Brennan CA, Nesbit ME. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993;71:865–873.
- Weiss LM. Histiocytic and dendritic cell proliferations. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001. pp 1815–1846.
- Srivastava BI, Srivastava A, Srivastava MD. Phenotype, genotype and cytokine production in acute leukemia involving progenitors of dendritic Langerhans' cells. Leuk Res 1994;18:499–511.
- Okubo T, Asou N, Suzushima H, et al Reactive histiocytosis during initial remission induction therapy for acute myeloblastic leukemia. Rinsho Ketsueki 1992;33:1824–1828.
- Christie LJ, Evans AT, Bray SE, et al Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? Hum Pathol 2006;37:32–39.
- Lewis RE, Cruse JM, Sanders CM, Webb RN, Suggs JL. Aberrant expression of T-cell markers in acute myeloid leukemia. Exp Mol Pathol 2007;83:462–463.
- Breccia M, Mandelli F, Petti MC, et al Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution. Leuk Res 2004;28:1165–1169.